Clinical Trial Update: A Phase 2 Study With Panzem in Patients With Relapsed or Plateau Phase Multiple Myeloma [Phase 2]

View source ↗

Summary

A Phase 2 study of Panzem (2-methoxyestradiol) in patients with relapsed or plateau phase multiple myeloma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Panzem (2-methoxyestradiol)

Snippet

Sponsor: CASI Pharmaceuticals, Inc. | Conditions: Relapsed Multiple Myeloma, Plateau Phase Multiple Myeloma | Phase 2 | Status: COMPLETED